Skip to main content
BMC Complementary Medicine and Therapies logoLink to BMC Complementary Medicine and Therapies
. 2022 Mar 27;22:91. doi: 10.1186/s12906-022-03573-6

The prevalence of using complementary and alternative medicine products among patients with pressure ulcer

Niloofar Karimianfard 1, Azita Jaberi 1,2,
PMCID: PMC8958779  PMID: 35346164

Abstract

Background

The use of complementary and alternative medicine (CAM) therapies has increased in recent years throughout the world and in Iran. Nonetheless, there are limited data about the prevalence of their use. This study aimed to assess the prevalence of using CAM therapies among patients with pressure ulcer (PU).

Methods

This cross-sectional study was conducted in 2019–2020. Participants were 299 patients with PU conveniently selected from wound clinics and healthcare settings in Shiraz, Iran. A demographic questionnaire and the International Questionnaire to Measure Use of CAM were used for data collection. The data were analyzed using the SPSS software (v. 22.0).

Results

All 299 participants completed the study. Their mean age was 59.56 ± 18.76 years. The most common CAM therapies used for PU management were herbal products (100%), vitamin supplementation therapy (45.2%), spiritual therapies (21.7%), wet cupping therapy (16.4%), leech therapy (9.4%), acupuncture (1.7%), dry cupping therapy (1.3%), and massage therapy (1.3%). The most common herbal product used for PU management was Pistacia atlantica gum either alone or in combination with other herbal products (15.5%). The use of CAM therapies had significant relationship with participants’ age, underlying conditions, and PU stage (P < 0.05) and the most significant predictor of using herbal products for PU was educational level (P < 0.05, OR = 5.098).

Conclusions

The use of CAM therapies, particularly herbal products, for PU management is high in Iran. Quality public education and close professional supervision are needed for the safe use of these products.

Keywords: Pressure ulcer, Complementary and alternative medicine, Herbal products

Background

Pressure ulcer (PU) is the third most costly health problem after cancer and cardiovascular disease [1]. The National Pressure Ulcer Advisory Panel (NPUAP) defines PU as localized damage to the skin usually over bony prominences due to pressure or shear and classifies it based on its severity and extent to stage 1 to 4, unstagable, and deep tissue injury [2]. The prevalence of PU is 4%–38% in intensive care units, 4.7%–31.2% in general hospital wards, 4.6%–20.7% in nursing homes, and 19% in home settings [36]. Two meta-analyses reported that the global prevalence of PU is 12.8% [7] and 26.6% [8]. The prevalence of PU is 14.5% in Europe, 13.6% in North America, 12.6% in the Middle East, 12.7% in South America, 9% in Australia, and 3% in Asia [7]. PU prevalence in hospitals in Iran is 5.1%–39.2% [9]. A meta-analysis reported that PU prevalence in intensive care units in Iran is 19.57% [10].

PU has many negative consequences for afflicted patients, their families, and healthcare systems. It causes pain and disability, prolongs the length of hospital stay, and increases morbidity and mortality rates [11]. PU-induced stress and altered body image also undermine individuals’ ability to participate in physical and social activities and reduce their quality of life [4]. Studies showed that sixty million people annually die due to PU-related problems [12]. PU also increases financial costs in healthcare systems [13], wastes healthcare providers’ time, and imposes heavy costs on healthcare systems and families [5]. A systematic review showed that the daily cost of PU management was 1.7–470.5 Euros per patient [14]. Estimates show that PU can increase the costs of nursing care by 50% [3].

The conventional treatments for PU include removal of pressure, position change, wound washing, infection management, use of topical ointments and dressings, establishment of appropriate nutrition, and use of advanced dressings and surgical interventions [15]. Despite the wide use of these treatments, the prevalence of PU has not significantly decreased in recent years [10], PU is still a major clinical problem and a significant burden to patients and communities, and hence, more effective therapeutic strategies are needed for PU management [15].

Complementary and alternative medicine (CAM) therapies have potentials for PU management [16]. CAM is a type of healthcare services which includes a wide range of therapies including herbal therapy, acupuncture, yoga, and massage therapy [17]. Studies showed that the prevalence of using CAM therapies for at least one time in life was 52%–69% in Australia, 33% in the United Kingdom, 66%–75% in Belgium, 49% in France, 18% in Netherlands, 20%–30% in Germany, 59% in Canada, 62% in the United States, 76% in Singapore, and 50% in Japan [1820]. The World Health Organization estimates that 80% of the world population, i.e. around four billion people, use herbal products for at least one time in their life for the management of their health problems, though the prevalence of using different CAM therapies varies in different areas in the world depending on culture, history, educational level, and personal desires [21]. In some countries, the prevalence of using CAM therapies is as high as 80%. Healthcare authorities in different countries have heavily invested in CAM therapies due to dissatisfaction with conventional medicine therapies and their side effects, particularly in the area of managing chronic illnesses [22].

The prevalence of CAM use is also high and is progressively increasing in Iran due to factors such as their easy accessibility and low costs [23]. The official statistics of the Ministry of Health of Iran show that the rate of selling medicinal plants in Iran reached from seven billion Riyals in 1997 to 37 billion Riyals in 2001 and eighty billion Riyals in 2003 and reached from 0.3% in 2005 to 3% in recent years [24]. Meanwhile, studies showed the increasing prevalence of over-the-counter use of CAM therapies in Iran which can predispose users to significant side effects and complications. Nonetheless, there are limited data about the use, effectiveness, and costs of CAM therapies for PU management. Limited data in this area interfere with the effective and safe use of CAM therapies for PU management. Therefore, the present study was conducted to address these gaps. The aim of the study was to assess the prevalence of using CAM therapies among patients with pressure ulcer.

Methods

This cross-sectional study was conducted in 2019–2020. Study setting was wound clinics in Shiraz, Iran, which provided wound care services to patients with different types of wounds, as well as healthcare settings in Shiraz, Iran, which provided healthcare services to patients with different health problems. Sampling was performed conveniently. Inclusion criteria were affliction by PU due to problems such as spinal plegia, stroke, accidents, or chronic conditions which required complete bed rest, and use of CAM therapies for PU management. Patients with other types of wound, such as wounds caused by burn injuries or chemicals were not included. Sample size was calculated using the Cochran formula (n=Z2pq/d2) and the results of a systematic review which reported that the prevalence of PU in Iran was 19% [25]. Accordingly, with a d of 0.05, a Z of 1.96, and a p of 0.19, sample size was determined to be 236. Nonetheless, sample size was increased to 299 in order to compensate probable withdrawals.

Data were collected using a demographic questionnaire and the third part of the International Questionnaire to Measure Use of CAM. The items of the demographic questionnaire were on participants’ age, gender, underlying conditions, duration of affliction by PU, PU characteristics, medications, routes of taking medications, medication side effects, and reasons for using CAM therapies.

The International Questionnaire to Measure Use of CAM was developed and psychometrically evaluated by Quandt and colleagues (2009). This questionnaire has four main parts on different CAM therapies, resources which provide CAM therapies, use of herbal products and dietary supplements, and self-care activities. In each part, respondents are asked to report their use of CAM therapies within the past twelve months and at the present time, their reasons for such use, effectiveness of the used CAM therapies, and informing physicians about such use. Among the reasons for using CAM therapies are management of an acute disease, management of a chronic disease, and promotion of health or well-being. The effectiveness of the used CAM therapies is assessed on a four-point Likert scale from “I don’t know” to “Great”. Responses to each part are reported as frequency measures. This questionnaire was developed by a panel of experts and the results of a pilot study showed that its items were comprehensible for respondents, though its developers highlighted the necessity of further studies for confirming its validity and reliability in different settings [26]. Scholars in several earlier studies translated this questionnaire into German, French, Korean, Spanish, and Italian and reported its weak to acceptable face validity [2731]. A former study in Iran translated this questionnaire into Persian and confirmed its face validity through a pilot study on twenty healthy people and its content validity through a Delphi panel of experts [32].

For data collection, we referred to the study setting together with three research assistants and completed the study instruments for eligible participants through the interview method.

Data analysis

The SPSS software (v. 22.0) was used for data analysis. Data were described through the measures of descriptive statistics, namely mean, standard deviation, absolute frequency, and relative frequency. The relationship of using CAM therapies with demographic characteristics was assessed through the Chi-square test, while the effects of demographic characteristics on CAM use were assessed through the logistic regression analysis.

Ethical considerations

The Ethics Committee of Shiraz University of Medical Sciences, Shiraz, Iran, approved this study (code: IR.SUMS.REC.1398.539). All methods were carried out in accordance with relevant guidelines and regulations and the Declaration of Helsinki. Necessary permissions for the study were obtained from the Research Administration of that university. Participants were ensured of data confidentiality and their informed consent for participation was secured.

Results

In total, 299 patients with PU were assessed. Their mean age was 59.56 ± 18.76 years and they were mostly female (54.2%). The most common cause of PU was fracture (33.78%), the most common site of PU was on the sacrum or the buttocks, and the most common underlying condition was diabetes mellitus (64.2%).

Respecting the use of CAM therapies, all participants reported the use of herbal products (100%). Besides herbal products, the prevalence of using other CAM therapies was 1.7% for acupuncture, 16.4% for wet cupping therapy, 1.3% for dry cupping therapy, 1.3% for massage therapy, 9.4% for leech therapy, 45.2% for vitamin supplementation therapy, and 21.7% for spiritual therapies. None of the participants reported using homeopathy, yoga, energy therapy, and physical exercise for PU management.

The most common herbal product used for PU management was Pistacia atlantica gum either alone or in combination with other herbal products (15.5%). Table 1 shows the prevalence of using different herbal products for PU management. It is noteworthy to mention that all herbal products were applied topically.

Table 1.

The frequency of using herbal products for PU management

CAM products N %
Honey Alone 20 6.7
With silver 1 0.3
With Oliveria decumbens 1 0.3
With anbernesa 2 0.6
With fennel flower 1 0.3
With coconut oil, Aloe vera 1 0.3
With olive oil, Prunus scoparia gum, chamomile 4 1.3
With turmeric 2 0.7
With turmeric, Aloe vera, Rosa damascena oil, Amygdalus communis L. var. dulcis 1 0.3
With sesame oil, Mummy 1 0.3
Total 34 11.1
Pistacia atlantica gum Alone 11 3.7
With Ghee 33 10.9
With Pinus eldarica gum 1 0.3
With Pistacia atlantica leaves 1 0.3
With Pistacia atlantica wood 1 0.3
Total 47 15.5
Teucrium polium and anbernesa Alone 7 2.3
With chamomile 7 0.3
With Artemisia vulgaris 1 0.3
Total 9 2.9
Aloe vera 14 4.7
Glycyrrhiza glabra 15 5
Henna with Ziziphus spina-christi, milk, lemon juice, Pistacia atlantica gum, and Ghee 5 1.5
Mummy Alone 7 2.3
With Pistacia atlantica gum and Ghee 1 0.3
With Trigonella foenum-graecum and Cuminum cyminum 1 0.3
With Peganum harmala 1 0.3
Total 10 3.2
Egg Egg albumin 1 0.3
Egg yolk 1 0.3
Egg yolk with burned Lens culinaris 1 0.3
Egg yolk with olive oil 1 0.3
Egg yolk with Prunus scoparia gum 1 0.3
Total 5 1.5
Burned or powdered Lens culinaris 8 2.7
Other 146 48.8

The main reasons for using CAM therapies were their greater effectiveness (49.8%), their greater effectiveness and lower costs (15.7%), and their greater effectiveness and easier accessibility (9%). Most participants had acquired their information about CAM therapies through their relatives (61.87%) and online search using mobile phone (31.1%). We had also asked participants whether they experienced the symptoms of wound infection, including exudates, discoloration, burning, pain, or fever, at one day, one week, two weeks, three weeks, and one month after the use of herbal products. As Table 2 shows, these symptoms were most common at one day after use (4.6%) and one week after the use (2.2%), while they were rare at two weeks, three weeks, and one month after the use (less than 1%).

Table 2.

The symptoms of PU infection after using herbal products

Symptoms Exudates Discoloration Burning Pain Fever
Time
N % N % N % N % N %
One day after 3 1 3 1 7 2.3 1 0.3 0 0
One week after 1 0.3 1 0.3 4 1.3 1 0.3 0 0
Two weeks after 1 0.3 0 0 2 0.7 0 0 0 0
Three weeks after 1 0.3 0 0 1 0.3 0 0 0 0
One month after 1 0.3 0 0 1 0.3 0 0 0 0

As Table 3 shows, participants used CAM therapies mainly for a chronic disease (71.9%) and considered them effective (54.5%). Moreover, only 21.1% of them reported that their physicians were aware of their use of CAM therapies.

Table 3.

Reasons for using CAM therapies, their effectiveness, and physician’s awareness of their use

Variables N %
Reasons for use Managing acute disease (less than one month) 23 7.7
Managing chronic disease (more than one month) 215 71.9
Effectiveness Great 163 54.5
Relative 76 25.4
Physician’s awareness Yes 63 21.1
No 178 59.5

The use of CAM therapies had no significant relationship with participants’ gender, educational level, occupation, and PU duration (P > 0.05). However, the use of CAM therapies had significant relationship with their age, underlying conditions, and PU stage so that the use of CAM therapies was greater among participants with diabetes mellitus, older age, and stage II PU (P < 0.05; Table 4).

Table 4.

The relationship of using CAM therapies with demographic characteristics

Characteristics Mean ± SD or N (%) P value
Age (years) 59.56 ± 18.76  < 0.001
Gender Female 162 54.2 0.151
Male 131 43.8
Underlying condition Diabetes mellitus 192 64.2  < 0.001
Cardiovascular disease 97 32.5
Renal disease 3 1
Liver disease 1 0.3
Other 6 2
Educational level Illiterate 103 34.4 0.142
Secondary 140 47.2
Bachelor’s 18 6
Master’s 1 0.3
Occupation Housewife 154 51.5 0.85
Employee 1 0.3
Retired 94 31.4
Unemployed 12 4
PU stage 1 5 1.7 0.001
2 208 69.6
3 58 19.4
4 7 2.3
PU duration One week 63 21.1 0.054
Two weeks 103 34.4
3 weeks 40 13.4
4 weeks 27 9
5 weeks 47 16.1

The results of the logistic regression analysis revealed that the most significant predictor of using herbal products for PU was educational level (P < 0.05, OR = 5.098; Table 5).

Table 5.

The results of the logistic regression analysis to determine the predictors of CAM therapy use

Independent variable Sig OR 95% CI for OR
Lower Upper
Step 1 Age 0.272 1.026 0.980 1.074
Gender 0.578 2.946 0.066 132.450
Educational level 0.028 5.098 1.190 21.847
Occupation 0.397 0.662 0.254 1.722
PU stage 0.214 0.514 0.180 1.468

Discussion

Study findings showed that in addition to conventional therapies, participants used CAM therapies, particularly herbal products. A former study also reported that the most prevalent CAM therapies used in chronic conditions were herbal products and spiritual therapy [32]. Some herbal products used in the present study, such as anbernesa, were burned and PU was smoked with them. Female donkey excrement, also known as AnbarNesa (or AnbarNasara), is gathered after labor and in the early spring. AnbarNesa smoke was also commonly utilized in Iranian traditional medicine to treat wounds, chickenpox blisters, oral inflammatory diseases such as aphthous ulcers, and inflammations such as otitis media and externa [33]. Such products have traditionally been used in the Iranian Traditional Medicine for managing infections, such as genitourinary tract infections, and recent studies confirmed their effectiveness in wound infection management and hence, they are currently used for wound dressing [33]. Our participants had also used egg albumin for PU management. Some previous studies also reported the use of egg albumin in hydrogel wound dressing [34, 35].

We also found that participants had used honey for PU management, either alone or in combination with other CAM products. Numerous studies have been conducted into the effects of honey on wound healing [36, 37]. Honey has antimicrobial effects, regulates the immune system, reduces edema and exudates, and hence is used for managing leishmaniosis wounds, surgical wounds, traumatic injuries, and chronic wounds such as PU [38].

Our participants also reported using Pistacia atlantica gum for PU management. This plant, its fruit, and its gum are used to treat a variety of disorders in Iran, either orally or topically. Previous research in Persian medicine has revealed that this herb can help with wound healing and the pain associated with other skin diseases [39]. Due to enhanced angiogenesis and increased bFGF and PDGF, Tanideh and colleagues discovered that the resin found in gum tissue is beneficial in treating burn wounds [40]. Pistacia atlantica is effective in managing deep wounds and preventing refractory wounds [41]. Study participants had also used Teucrium polium and Aloe vera for PU management. Aloe vera has known positive effects on wound healing [42]. Moreover, Teucrium polium and Aloe vera were reported to have positive effects on dermatologic disorders such as dandruff [43].

A very small number of participants had used Broadleaf plantain for PU management. Studies showed that due to its anti-inflammatory effects, Broadleaf plantain has beneficial effects on deep, infectious, chronic, and progressive wounds and burn injuries [44]. Some participants had used CAM therapies through burning, warming, or grinding them. For example, some of them had warmed egg yolk up to the extraction of its oil and then, applied it to PU. We did not find any study to support such use of CAM therapies. Some studies in Iran, particularly in southern areas of Iran, reported the use of herbal products such as Artemisia vulgaris, Teucrium polium, and Plantago ovate for wound management, though interventional studies are still needed to assess their mechanisms of action [45]. Another study reported the traditional use of coconut oil, Gentiana lutea, Commiphora Mukul, Teucrium polium, Punica granatum, Aloe vera, Adiantum capillus-veneris, Dutchman’s pipe, and Potentilla recta for wound management. Moreover, that study reported that while some herbal products has antimicrobial, anti-inflammatory, and antioxidant effects, there are no empirical data about their effects on wound healing. These products are Pistacia atlantica gum, camphor, chamomile, and rhamnus [16]. Our participants’ lack of knowledge about some herbal products highlights the importance of providing them with quality education by CAM specialists.

We also found that around half of the participants (45.2%) used vitamin supplements. A meta-analysis showed that using zinc-containing formula and oral supplements for eight weeks significantly improved PU healing [46]. On the other hand, none of our participants had used homeopathy, yoga, physical exercise, and energy therapy for PU management probably due to their limited knowledge about these CAM therapies. Moreover, one fifth of the participants reported the use of spiritual therapies such as praying. This rate is greater than the rates reported in previous studies in other countries [47] probably due to the religious beliefs of people in Iran [48]. Our findings also showed that 16.4% of participants had used wet cupping therapy. This rate is also greater than the rates reported in previous studies [30, 49]. The higher rate of using wet cupping therapy in the present study compared with former studies is attributable to the differences among studies respecting their participants’ characteristics, health status, and underlying conditions. Cupping treatment is an ancient form of alternative medicine in which a therapist suctions the skin with specific cups for a few minutes. Cupping is used to improve local blood and lymph circulation as well as relieve uncomfortable muscular tension. A glass cup is used in each of the various cupping techniques to induce suction over a painful spot. Cups are put to the undamaged skin in dry cupping, whereas in wet or bloody cupping, the skin is incised before the cups are administered [50]. Wet cupping therapy reduces the level of fibrinogen and alleviates inflammation and thereby, has potential positive effects on PU healing [51].

Our participants reported that their main reasons for using CAM therapies were their easy accessibility, lower costs, and greater effectiveness. Moreover, the main reason for using herbal products was to manage chronic conditions. These findings are in line with the findings of previous studies in Iran [9, 24]. However, most participants reported the use of CAM therapies without informing their physicians. This practice may expose them to problems such as drug interactions and medication side effects and highlights the importance of quality public education about using CAM therapies under professional supervision. Informing physicians about the use of CAM therapies facilitates recovery and helps physicians and patients better manage the side effects of therapies.

We also found that the main sources of our participants for obtaining information about CAM therapies were relatives and online search using mobile phone. This finding denotes that they had no information about the possibility of wound infection after using products such as unprocessed honey and anbernesa. Unprocessed honey and anbernesa may contain microorganisms and cause infection [33]. Quality public education about CAM therapies, particularly about the products of Iranian Traditional Medicine, should be provided through short message service, mobile phone applications, and multimedia programs in order to improve public awareness about these therapies and products.

An important finding of the present study was the low prevalence of PU infection despite the affliction of some participants by serious underlying conditions such as diabetes mellitus. Meanwhile, our findings showed that most participants had not used herbal products with known positive effects on wound healing such as Punica granatum, coriander, Rosa damascena, cinnamon, gum Arabic, grapevines, cinnamon extract, and the mucilage of Broadleaf plantain and Plantago ovate [52].

Concerning the findings, follow-up studies with doctors and nurses who specialize in wound care would be interesting to assess their knowledge of what their patients are using for PU management and to address the disconnection between patient confidence in prescribed medication and self-medication. Clinical investigations of herbal and other CAM PU treatment strategies are one of the study's implications. Furthermore, doctor and nurse education on the topic, as well as the formulation of national policy on the use of evidence-based CAM modalities for safe and cost-effective PU care, are both necessary.

Conclusions

This study shows the high prevalence of using CAM therapies, particularly herbal products, for PU management. Such use is mainly over-the-counter and without informing treating physicians and CAM specialists. Therefore, quality public education through mass media is recommended to improve public knowledge about CAM therapies, their uses, and their side effects. Improving healthcare providers’ and lay people’s knowledge about CAM therapies and the appropriate use of cost-effective CAM therapies in PU management can reduce the need for imported dressings which are expensive and poorly accessible.

Acknowledgements

The authors of the current study would like to express their sincerest gratitude to Shiraz University of Medical Sciences for financially supporting the research (grant No. IR.SUMS.REC.1398.539). They would also like to appreciate all the participants who cooperated in the study.

Authors’ contributions

AJ designed and supervised and directed the study, NK carried out the implementation, AJ and NK gathered the data, AJ performed the analysis, AJ and NK drafted the manuscript. All authors discussed the results, commented on the manuscript and approved the final manuscript.

Funding

Shiraz University of Medical Sciences financially supporting this research (grant No. IR.SUMS.REC.1398.539).

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Declarations

Ethics approval and consent to participate

The present study was approved by the Ethics Committee of Shiraz University of Medical Sciences (IR.SUMS.REC.1398.539). All necessary permissions for conducting the research were obtained from the relevant administrators and all methods were performed in accordance with the relevant guidelines and regulations. Furthermore, a session was held after the selection of participants for explaining the study objectives and procedures. Written informed consent forms were also taken from all participants.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Niloofar Karimianfard, Email: niloo.fard1212@gmail.com.

Azita Jaberi, Email: azita635@yahoo.com.

References

  • 1.Ogbera A, Dada O, Adeleye F, Jewo P. Complementary and alternative medicine use in diabetes mellitus. West Afr J Med. 2010;29(3):158–62. [DOI] [PubMed]
  • 2.National-Pressure-Ulcer-Advisory-Panel . Clinical Practice Guideline. Haesler E, editor. Perth. Australia: Cambridge Media; 2014. Prevention and Treatment of Pressure Ulcers. [Google Scholar]
  • 3.Moore ZEH, Webster J, Samuriwo R Moore ZEH, Webster J, Samuriwo R. Wound‐care teams for preventing and treating pressure ulcers. Cochrane Database Syst Rev. 2015;(9):CD011011. 10.1002/14651858.CD011011.pub2. [DOI] [PMC free article] [PubMed]
  • 4.Iranmanesh S, Tafti AA, Rafiei H, Dehghan M, Razban F. Orthopaedic nurses’ knowledge about pressure ulcers in Iran: a cross-sectional study. J Wound Care. 2013;22(3):138–43. doi: 10.12968/jowc.2013.22.3.138. [DOI] [PubMed] [Google Scholar]
  • 5.Gorecki C, Closs SJ, Nixon J, Briggs M. Patient-reported pressure ulcer pain: a mixed-methods systematic review. J Pain Symptom Manage. 2011;42(3):443–459. doi: 10.1016/j.jpainsymman.2010.11.016. [DOI] [PubMed] [Google Scholar]
  • 6.Serra R, Grande R, Buffone G, Gallelli L, Caroleo S, Tropea F, et al. Albumin administration prevents the onset of pressure ulcers in intensive care unit patients. Int Wound J. 2015;12(4):432–435. doi: 10.1111/iwj.12131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Li Z, Lin F, Thalib L, Chaboyer W. Global prevalence and incidence of pressure injuries in hospitalised adult patients: A systematic review and meta-analysis. Int J Nurs Stud. 2020;105:103546. doi: 10.1016/j.ijnurstu.2020.103546. [DOI] [PubMed] [Google Scholar]
  • 8.Labeau SO, Afonso E, Benbenishty J, Blackwood B, Boulanger C, Brett SJ, et al. Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study. Intensive Care Med. 2021;47:160–9. [DOI] [PMC free article] [PubMed]
  • 9.Farzaei F, Morovati MR, Farjadmand F, Farzaei MH. A mechanistic review on medicinal plants used for diabetes mellitus in traditional Persian medicine. J Evid-Based Complement Altern Med. 2017;22(4):944–955. doi: 10.1177/2156587216686461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Akhkand SS, Seidi J, Ebadi A, Gheshlagh RG. Prevalence of pressure ulcer in Iran's intensive care units: A systematic review and meta-analysis. Nurs Pract Today. 2020;7(1):12–20.
  • 11.Ferris A, Price A, Harding K. Pressure ulcers in patients receiving palliative care: a systematic review. Palliat Med. 2019;33(7):770–782. doi: 10.1177/0269216319846023. [DOI] [PubMed] [Google Scholar]
  • 12.Jackson D, Sarki AM, Betteridge R, Brooke J. Medical device-related pressure ulcers: A systematic review and meta-analysis. Int J Nurs Stud. 2019;92:109–120. doi: 10.1016/j.ijnurstu.2019.02.006. [DOI] [PubMed] [Google Scholar]
  • 13.Padula WV, Delarmente BA. The national cost of hospital-acquired pressure injuries in the United States. Int Wound J. 2019;16(3):634–640. doi: 10.1111/iwj.13071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Demarré L, Van Lancker A, Van Hecke A, Verhaeghe S, Grypdonck M, Lemey J, et al. The cost of prevention and treatment of pressure ulcers: a systematic review. Int J Nurs Stud. 2015;52(11):1754–1774. doi: 10.1016/j.ijnurstu.2015.06.006. [DOI] [PubMed] [Google Scholar]
  • 15.Mervis JS, Phillips TJ. Pressure ulcers: Prevention and management. J Am Acad Dermatol. 2019;81(4):893–902. doi: 10.1016/j.jaad.2018.12.068. [DOI] [PubMed] [Google Scholar]
  • 16.Hosseinkhani A, Falahatzadeh M, Raoofi E, Zarshenas MM. An evidence-based review on wound healing herbal remedies from reports of traditional Persian medicine. J Evid-Based Complement Altern Med. 2017;22(2):334–343. doi: 10.1177/2156587216654773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Quan H, Lai D, Johnson D, Verhoef M, Musto R. Complementary and alternative medicine use among Chinese and white Canadians. Can Fam Physician. 2008;54(11):1563–1569. [PMC free article] [PubMed] [Google Scholar]
  • 18.Hailemeskel B, Ziregbe E, Tran C, et al. Complementary and Alternative Medicine (CAM) Utilization by Howard University (HU) First Year Pharmacy Students: Survey and Review of Most Commonly Used Herbs. Curr Res Integr Med. 2017;2(3):37–41.
  • 19.Hamilton JL, Roemheld-Hamm B, Young DM, Jalba M, DiCicco-Bloom B. Complementary and alternative medicine in US family medicine practices: a pilot qualitative study. Altern Ther Health Med. 2008;14(3):22–7. [PubMed]
  • 20.Hall HG, Griffiths DL, McKenna LG. The use of complementary and alternative medicine by pregnant women: a literature review. Midwifery. 2011;27(6):817–824. doi: 10.1016/j.midw.2010.08.007. [DOI] [PubMed] [Google Scholar]
  • 21.World-Health-Organization. WHO traditional medicine strategy 2002–2005. Geneva: World Health Organization. 2002. 2015.
  • 22.Ernst E. Cost Effectiveness of Complementary Medicines. Focus Altern Complement Ther. 2011;16(2):184. [Google Scholar]
  • 23.Aghaei A, Khalili M. Challenges and Opportunities of Promoting Complementary and Alternative Medicine (CAM) in Iran’s Internet Arena. J Consum Health Internet. 2018;22(2):142–149. [Google Scholar]
  • 24.Sajjadian A, Moradi M, HajiMahmoodi M, MirMolaei T. Complementary medicine use among cancer patients after excluding the praying as a complementary therapy. Breast Dis J. 2009;2(1):15–22. [Google Scholar]
  • 25.Karimian M, Sarokhani D, Sarokhani M, Sayehmiri K, Mortazavi Tabatabai SA. Prevalence of bedsore in Iran: a systematic review and meta-analysis. J Mazandaran Univ of Med Sci. 2016;26(136):202–10. [Google Scholar]
  • 26.Quandt SA, Verhoef MJ, Arcury TA, Lewith GT, Steinsbekk A, Kristoffersen AE, et al. Development of an international questionnaire to measure use of complementary and alternative medicine (I-CAM-Q) J Altern Complement Med. 2009;15(4):331–339. doi: 10.1089/acm.2008.0521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Druart L, Pinsault N. The I-CAM-FR: A French translation and cross-cultural adaptation of the I-CAM-Q. Med. 2018;5(3):72. doi: 10.3390/medicines5030072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Eardley S, Bishop FL, Cardini F, Santos-Rey K, Jong MC, Ursoniu S, et al. A pilot feasibility study of a questionnaire to determine European Union-wide CAM use. Complement Med Res. 2012;19(6):302–310. doi: 10.1159/000345839. [DOI] [PubMed] [Google Scholar]
  • 29.Esteban S, Peña FV, Terrasa S. Translation and cross-cultural adaptation of a standardized international questionnaire on use of alternative and complementary medicine (I-CAM-Q) for Argentina. BMC Complement Altern Med. 2016;16(1):1–7. doi: 10.1186/s12906-016-1074-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Lee JA, Sasaki Y, Arai I, Go H-Y, Park S, Yukawa K, et al. An assessment of the use of complementary and alternative medicine by Korean people using an adapted version of the standardized international questionnaire (I-CAM-QK): a cross-sectional study of an internet survey. BMC Complement Altern Med. 2018;18(1):1–11. doi: 10.1186/s12906-018-2294-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Re ML, Schmidt S, Güthlin C. Translation and adaptation of an international questionnaire to measure usage of complementary and alternative medicine (I-CAM-G) BMC Complement Altern Med. 2012;12(1):1–10. doi: 10.1186/1472-6882-12-259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Farhoudi F, Salehi A, Vojoud M, Vardanjani HM. Assessment of the complementary and integrative medicine utilization among patients with multiple sclerosis using a translated and adapted version of the international questionnaire (I-CAM-QP): A cross-sectional study in Southern Iran. Complement Ther Med. 2019;46:47–53. doi: 10.1016/j.ctim.2019.07.016. [DOI] [PubMed] [Google Scholar]
  • 33.Joharchi K, Anaraki Firouz SM, Mashhadiabbas F, Mansouri A, Shafiee H, Taheri JB. Wound Healing and the Effect of ANNAS; a New Product of AnbarNesa. Jundishapur J  Nat Pharm Prod. 2020;15(2):e66668.
  • 34.Jahani-Javanmardi A, Sirousazar M, Shaabani Y, Kheiri F. Egg white/poly (vinyl alcohol)/MMT nanocomposite hydrogels for wound dressing. J Biomater Sci Polym Ed. 2016;27(12):1262–1276. doi: 10.1080/09205063.2016.1191825. [DOI] [PubMed] [Google Scholar]
  • 35.Sirousazar M, Jahani-Javanmardi A, Kheiri F, Hassan ZM. In vitro and in vivo assays on egg white/polyvinyl alcohol/clay nanocomposite hydrogel wound dressings. J Biomater Sci Polym Ed. 2016;27(16):1569–1583. doi: 10.1080/09205063.2016.1218210. [DOI] [PubMed] [Google Scholar]
  • 36.Moghazy A, Shams M, Adly O, Abbas A, El-Badawy M, Elsakka D, et al. The clinical and cost effectiveness of bee honey dressing in the treatment of diabetic foot ulcers. Diabetes Res Clin Pract. 2010;89(3):276–281. doi: 10.1016/j.diabres.2010.05.021. [DOI] [PubMed] [Google Scholar]
  • 37.Laila S, Fatemeh E, Lida B. Treatment of diabetic foot ulcer with medicinal leech therapy and honey curcumin dressing: a case report. Trad Med Res. 2019;4(6):338. [Google Scholar]
  • 38.Martinotti S, Ranzato E. Honey, wound repair and regenerative medicine. J Funct Biomater. 2018;9(2):34. doi: 10.3390/jfb9020034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Mahjoub F, Rezayat KA, Yousefi M, Mohebbi M, Salari R. Pistacia atlantica Desf. a review of its traditional uses, phytochemicals and pharmacology. Journal of medicine and life. 2018;11(3):180. doi: 10.25122/jml-2017-0055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Tanideh N, Masoumi S, Hosseinzadeh M, Safarpour AR, Erjaee H, Koohi-Hosseinabadi O, et al. Healing effect of pistacia atlantica fruit oil extract in acetic Acid-induced colitis in rats. Iranian J Med Sci. 2014;39(6):522. [PMC free article] [PubMed] [Google Scholar]
  • 41.Parvizi MM, Zare F, Handjani F, Nimrouzi M, Zarshenas MM. Overview of herbal and traditional remedies in the treatment of cutaneous leishmaniasis based on Traditional Persian Medicine. Dermatol Ther. 2020;33(4):e13566. [DOI] [PubMed]
  • 42.de Oliveira ACL, Tabrez S, Shakil S, Khan MI, Asghar MN, Matias BD, et al. Mutagenic, antioxidant and wound healing properties of Aloe vera. J Ethnopharmacol. 2018;227:191–197. doi: 10.1016/j.jep.2018.08.034. [DOI] [PubMed] [Google Scholar]
  • 43.Zareian MA, Yargholi A, Khalilzadeh S, Shirbeigi L. Etiology and treatment of dandruff according to Persian medicine. Dermatol Ther. 2019;32(6):e13102. doi: 10.1111/dth.13102. [DOI] [PubMed] [Google Scholar]
  • 44.Najafian Y, Hamedi SS, Farshchi MK, Feyzabadi Z. Plantago major in Traditional Persian Medicine and modern phytotherapy: a narrative review. Electron Physician. 2018;10(2):6390. doi: 10.19082/6390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Moradi L, Dolatkhahi M, Darabi H, Nabipour I. Ethnopharmacology of medicinal plants in Genaveh port. ISMJ. 2014;17(5):959–73. [Google Scholar]
  • 46.Cereda E, Neyens J, Caccialanza R, Rondanelli M, Schols J. Efficacy of a disease-specific nutritional support for pressure ulcer healing: a systematic review and meta-analysis. J Nutr Health Aging. 2017;21(6):655–661. doi: 10.1007/s12603-016-0822-y. [DOI] [PubMed] [Google Scholar]
  • 47.Jazieh AR, Al Sudairy R, Abulkhair O, Alaskar A, Al Safi F, Sheblaq N, et al. Use of complementary and alternative medicine by patients with cancer in Saudi Arabia. J Altern Complement Med. 2012;18(11):1045–1049. doi: 10.1089/acm.2011.0266. [DOI] [PubMed] [Google Scholar]
  • 48.Jaberi A, Momennasab M, Cheraghi M, Yektatalab S, Ebadi A. Spiritual Health as Experienced by Muslim Adults in Iran: A Qualitative Content Analysis. Shiraz E-Med J. 2019;20(12):e88715.
  • 49.Hashempur MH, Heydari M, Mosavat SH, Heydari ST, Shams M. Complementary and alternative medicine use in Iranian patients with diabetes mellitus. J Integr Med. 2015;13(5):319–325. doi: 10.1016/S2095-4964(15)60196-0. [DOI] [PubMed] [Google Scholar]
  • 50.Qureshi NA, Ali GI, Abushanab TS, El-Olemy AT, Alqaed MS, El-Subai IS, et al. History of cupping (Hijama): a narrative review of literature. J Integr Med. 2017;15(3):172–181. doi: 10.1016/S2095-4964(17)60339-X. [DOI] [PubMed] [Google Scholar]
  • 51.Nimrouzi M, Mahbodi A, Jaladat A-M, Sadeghfard A, Zarshenas MM. Hijamat in traditional Persian medicine: risks and benefits. J Evid-Based Complement Altern Med. 2014;19(2):128–136. doi: 10.1177/2156587214524578. [DOI] [PubMed] [Google Scholar]
  • 52.Hamedi A, Zarshenas MM, Sohrabpour M, Zargaran A. Herbal medicinal oils in traditional Persian medicine. Pharm Biol. 2013;51(9):1208–1218. doi: 10.3109/13880209.2013.777462. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.


Articles from BMC Complementary Medicine and Therapies are provided here courtesy of BMC

RESOURCES